Researcher’s View: Sourcing accurate and reliable quantitative data on Tanzania’s pharmaceutical market remains challenging due to substandard audits, porous sales channels, a high prevalence of counterfeits, questionable national statistics, dispensing without prescriptions, sizeable ‘grey markets’ and the widespread use of traditional remedies. Researcher takes into account the import dependence of countries for medicines and assumes that economic growth as well as the resulting increase in the size of Tanzania’s middle-class population will lead to an increase in demand for medicines. Moreover, the country’s rising population and increasing urbanization will increase spending on medicines over the forecast period.
Nevertheless, due to currently low purchasing power, generic drugs comprise the majority of Tanzania’s pharmaceuticals market. We also do not expect Tanzania’s reliance on imported drugs to decrease in the short term, even though the government has been encouraging the production of drugs locally.
Headline Expenditure Projections
Pharmaceuticals: TZS693.94bn (USD429mn) in 2013 to an expected TZS806.32bn (USD498mn) in 2014; +16.2% growth in local currency terms and +16.1% in US dollar terms.
Healthcare: TZS 4,120bn (USD2.55bn) in 2013 to TZ 5,130bn (USD3.17bn) in 2014; 24.5% growth in local currency terms and 24.4% in US dollar terms. Inquire before Buying @ http://www.lifescienceindustryresearch.com/inquire-before-buying?rname=13784 . Table Of Contents
Researcher Industry View 7
Business Environment 14
Industry Forecast 15
Pharmaceutical Market Forecast 15
Table: Pharmaceutical Sales, Historical Data And Forecasts (Tanzania 2010-2018) 17 Healthcare Market Forecast 18
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Tanzania 2010-2018) 20 Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Tanzania 2010-2018) 20 Table: Private Healthcare...
Please join StudyMode to read the full document